In ischemic stroke without large or medium vessel occlusion, tirofiban increased likelihood of an excellent outcome

ACP Journal Club3 October 2023In ischemic stroke without large or medium vessel occlusion, tirofiban increased likelihood of an excellent outcomeMark J. Alberts, MDMark J. Alberts, MDHartford HealthCare and Hartford Hospital, Hartford, Connecticut, USA (M.J.A.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/J23-0074 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationZi W, Song J, Kong W, et al; RESCUE BT2 Investigators. Tirofiban for stroke without large or medium-sized vessel occlusion. N Engl J Med. 2023;388:2025-2036. https://pubmed.ncbi.nlm.nih.gov/37256974Clinical Impact RatingsEmergency Med: Hospitalists: GIM/FP/GP: Neurology: References1. Gellatly RM, Connell C, Tan C, et al. Trends in use and outcomes associated with glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Ann Pharmacother. 2020;54:414-422. [PMID: 31766865] Google Scholar2. Cohen M, Diez JE, Levine GN, et al; ACC; AHA. Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report—III. J Invasive Cardiol. 2007;19:525-538. [PMID: 18180524] Google Scholar3. Brown DL, Levine DA, Albright K, et al; American Heart Association Stroke Council. Benefits and risks of dual versus single antiplatelet therapy for secondary stroke prevention: a systematic review for the 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2021;52:e468-e479.[PMID: 34024115] Google Scholar Author, Article, and Disclosure InformationAuthors: Mark J. Alberts, MDAffiliations: Hartford HealthCare and Hartford Hospital, Hartford, Connecticut, USA (M.J.A.)Disclosures: The commentator has reported no disclosures of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=J23-0074.This article was published at Annals.org on 3 October 2023.ACP Journal Club is editorially independent from Annals of Internal Medicine. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics October 2023Volume 176, Issue 10Page: JC111KeywordsAntiplatelet therapyAspirinHemorrhageIschemic strokeMyocardial infarctionSafetySmoking habitsStroke ePublished: 3 October 2023 Issue Published: October 2023 Copyright & PermissionsCopyright © 2023 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...